Skip to content

Clinical trials

Colonic Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Country / region: Australia Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20061
20082
20093
20102
20111
20141
20151
20174
20181
20195
20205
20213
20222
20232
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting9
Active, not recruiting9
Terminated6
Unknown status4
Withdrawn1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Pfizer3
Amgen2
GlaxoSmithKline2
Incyte Corporation2
Novartis Pharmaceuticals2
Peter MacCallum Cancer Centre, Australia2
Sanofi2
Western Sydney Local Health District2
AbbVie (prior sponsor, Abbott)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms47
Colorectal Neoplasms27
Rectal Neoplasms21
Carcinoma, Non-Small-Cell Lung8
Neoplasm Metastasis8
Lung Neoplasms7
Neoplasms7
Breast Neoplasms6
Thyroid Neoplasms6
Neoplasms by Site5

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.